Endonovo Therapeutics Inc. (ENDV) Appoints National Leader in Pain Management to Scientific Advisory Board
Appointment of Dr. Steven Levin of Johns Hopkins University to Endonovo’s scientific advisory board is expected to help facilitate the introduction of Endonovo’s non-invasive bio-electrical medical devices to hospitals and clinics The global wearable medical devices market is expected to grow to nearly $67 billion by 2026 at a CAGR of 26.1 percent Endonovo holds 27 patents and numerous trademarks for several proprietary technologies and medical devices Endonovo Therapeutics Inc. (OTCQB: ENDV), a commercial-stage developer of non-invasive electroceutical therapeutic devices, has appointed Dr. Steven Levin, M.D., a national leader in the field of pain management, to its scientific advisory board. Levin…